TJX Bioengineering
Industrial Machinery & Equipment · Massachusetts, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
28 Church St Ste 14956, Winchester, Mass...Website
www.tjxbio.comRevenue
$5.4 MillionIndustry
About TJX Bioengineering
TJXBIO is a pioneer in bioreactor innovations, specializing in advanced high-throughput parallel bioreactor systems for fermentation and cell culture. Their products are designed to empower bioprocess engineers and scientists, offering a complete solution that integrates hardware and software for effective research and development. Targeting both small teams and large research institutions, TJXBIO's technology supports microbial fermentation and mammalian cell cultures through a versatile platform. The company aims to revolutionize the biotech industry with its innovative Bioreactor as a Service (BaaS) business model and intelligent bioprocess development assistant, Mia.Explore more
SIC Code 38,382NAICS Code 33,333Show moreTJX Bioengineering Org Chart
Compare Similar Companies to TJX Bioengineering
Compare insights from companies similar to TJX Bioengineering, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$15.4M
11-50
Private
-
2004
EM
Edward McIlveenChief Investment Officer & Vice President, Investment Consulting
TJX Bioengineering Tech Stack
Top Industrial Machinery & Equipment Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding TJX Bioengineering
Sign Up For FreeTo access detailed company insights
TJXBIO is a pioneer in bioreactor innovations, specializing in advanced high-throughput parallel bioreactor systems for fermentation and cell culture. Their products are designed to empower bioprocess engineers and scientists, offering a complete solution that integrates hardware and software for effective research and development. Targeting both s... Read More